The U.S. Food and Drug Administration approved Aduhelm for the treatment of Alzheimers, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides a meaningful therapeutic advantage over existing treatments.
- Read more about FDA Grants Accelerated Approval for Alzheimer’s Drug
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/fda-grants-accelerated-approval-for-alzheimers-drug
No comments:
Post a Comment